Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200625535> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4200625535 endingPage "165" @default.
- W4200625535 startingPage "156" @default.
- W4200625535 abstract "Objective: Allergen-specific immunotherapy (allergen-SIT) is a treatment method with variable efficacy in allergic diseases. This study aimed to investigate the effectiveness of allergen immunotherapy, frequency of LRs and SRs and variables affecting these parameters in patients who underwent allergen-SIT. Materials and Methods: In this study, the recorded data of 81 patients, who received subcutaneous (SCIT) or sublingual (SLIT) allergen immunotherapy for respiratory allergic diseases between 2014 and 2019, were analyzed. In asthma and/or allergic rhinoconjunctivitis (ARC) patients, the effectiveness of treatment was evaluated by analysing the change rates in disease symptom, medication and combined scores (symptom + medication) and visual analog score (VAS). Treatment success was defined by the degree of decrease in scores as; high response above 50%; low response between 20-50%; and failure <20%.Results: The mean age of allergen-SIT initiation was 11.4± 3.1 years. Diagnostic distributions of the patients were asthma (± ARC) in 64.2%, and ARC (without asthma) in 35.8%. The mode of allergen-SIT was SCIT in 77.8% (65% asthma and 35% ARC) and SLIT in 22.2% (61.1% asthma and 38.9% ARC). The main allergens used in allergen-SIT were mite (79%), grass-grain pollen (33.3%), alternaria (9.9%) and olea (8.6%). There was a significant decrease in symptoms, medication, combined and VAS scores in the asthma and ARC groups (p <0.0001), when end-SCIT values were compared to baseline. SLIT also resulted in significant decreases in these scores except asthma medication score. Among the asthma patients the rate of high-responders was 88.8% by SCIT and 50% by SLIT, according to combined asthma score. Among the ARC (without asthma) patients the rate of high-responders was 100% for both SCIT and SLIT. SCIT resulted in local (LR) and systemic side effects (SR) in 18% and 0.6% (all Grade I and Grade II) of the total injections performed. A high number of total injections was significantly associated with higher LR and SR rates. While LR was observed in 16.6% of the patients who underwent SLIT, no systemic reaction was found in any of the patients. Conclusion: SCIT was highly successful in the treatment of asthma and ARC in terms of the degree of therapeutic response. SLIT resulted in a high rate of good response in ARC patients, but a lower response degree in asthmatic patients. Systemic side effects were very low as a result of close risk monitoring and the dose adjustments performed. Keywords: Allergen-specific immunotherapy, SCIT, SLIT, efficacy, symptom score, medication score, visual analog score, side effects" @default.
- W4200625535 created "2021-12-31" @default.
- W4200625535 creator A5001178068 @default.
- W4200625535 creator A5012888171 @default.
- W4200625535 creator A5021747761 @default.
- W4200625535 creator A5024698693 @default.
- W4200625535 creator A5038821032 @default.
- W4200625535 creator A5051148434 @default.
- W4200625535 creator A5073768218 @default.
- W4200625535 date "2021-12-22" @default.
- W4200625535 modified "2023-09-26" @default.
- W4200625535 title "Standardized Quantitative Evaluation of Clinical Effectiveness and Side Effect Profile of Subcutaneous and Sublingual Allergen-Specific Immunotherapy in Children: A 5-Year Single Center Experience" @default.
- W4200625535 doi "https://doi.org/10.21911/aai.652" @default.
- W4200625535 hasPublicationYear "2021" @default.
- W4200625535 type Work @default.
- W4200625535 citedByCount "0" @default.
- W4200625535 crossrefType "journal-article" @default.
- W4200625535 hasAuthorship W4200625535A5001178068 @default.
- W4200625535 hasAuthorship W4200625535A5012888171 @default.
- W4200625535 hasAuthorship W4200625535A5021747761 @default.
- W4200625535 hasAuthorship W4200625535A5024698693 @default.
- W4200625535 hasAuthorship W4200625535A5038821032 @default.
- W4200625535 hasAuthorship W4200625535A5051148434 @default.
- W4200625535 hasAuthorship W4200625535A5073768218 @default.
- W4200625535 hasBestOaLocation W42006255351 @default.
- W4200625535 hasConcept C126322002 @default.
- W4200625535 hasConcept C199215989 @default.
- W4200625535 hasConcept C203014093 @default.
- W4200625535 hasConcept C207480886 @default.
- W4200625535 hasConcept C2776042228 @default.
- W4200625535 hasConcept C2778166374 @default.
- W4200625535 hasConcept C2779350572 @default.
- W4200625535 hasConcept C2779787640 @default.
- W4200625535 hasConcept C2780510475 @default.
- W4200625535 hasConcept C54355233 @default.
- W4200625535 hasConcept C71924100 @default.
- W4200625535 hasConcept C86803240 @default.
- W4200625535 hasConceptScore W4200625535C126322002 @default.
- W4200625535 hasConceptScore W4200625535C199215989 @default.
- W4200625535 hasConceptScore W4200625535C203014093 @default.
- W4200625535 hasConceptScore W4200625535C207480886 @default.
- W4200625535 hasConceptScore W4200625535C2776042228 @default.
- W4200625535 hasConceptScore W4200625535C2778166374 @default.
- W4200625535 hasConceptScore W4200625535C2779350572 @default.
- W4200625535 hasConceptScore W4200625535C2779787640 @default.
- W4200625535 hasConceptScore W4200625535C2780510475 @default.
- W4200625535 hasConceptScore W4200625535C54355233 @default.
- W4200625535 hasConceptScore W4200625535C71924100 @default.
- W4200625535 hasConceptScore W4200625535C86803240 @default.
- W4200625535 hasIssue "3" @default.
- W4200625535 hasLocation W42006255351 @default.
- W4200625535 hasOpenAccess W4200625535 @default.
- W4200625535 hasPrimaryLocation W42006255351 @default.
- W4200625535 hasRelatedWork W1027324538 @default.
- W4200625535 hasRelatedWork W2015217102 @default.
- W4200625535 hasRelatedWork W2035048904 @default.
- W4200625535 hasRelatedWork W2111715937 @default.
- W4200625535 hasRelatedWork W2123764936 @default.
- W4200625535 hasRelatedWork W2619197634 @default.
- W4200625535 hasRelatedWork W3035586057 @default.
- W4200625535 hasRelatedWork W3111508780 @default.
- W4200625535 hasRelatedWork W3134402445 @default.
- W4200625535 hasRelatedWork W3208103490 @default.
- W4200625535 hasVolume "19" @default.
- W4200625535 isParatext "false" @default.
- W4200625535 isRetracted "false" @default.
- W4200625535 workType "article" @default.